Immunotherapy and neuroimmunology in Alzheimer’s disease: a perspective from the blood

Immunotherapy and neuroimmunology in Alzheimer’s disease: a perspective from the blood–brain barrier

Published:2010-01 Issue:1 Volume:2 Page:1-3
ISSN:1750-743X
Container-title:Immunotherapy
language:en
Short-container-title:Immunotherapy

Author:

Banks William A¹

Affiliation:

1. GRECC, Veterans Affairs Medical Center, St Louis & Saint Louis University School of Medicine, Division of Geriatrics, Department of Internal Medicine, 915 N Grand Blvd, St Louis, MO 63106, USA.

Publisher

Future Medicine Ltd

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.futuremedicine.com/doi/pdf/10.2217/imt.09.72

Reference18 articles.

1. Brain-immune communication pathways

2. Effect of LPS on the permeability of the blood–brain barrier to insulin

3. Rapid Modulation of P-Glycoprotein-Mediated Transport at the Blood-Brain Barrier by Tumor Necrosis Factor-α and Lipopolysaccharide

4. The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer's type

5. Cerebrovascular Degeneration Is Related to Amyloid-? Protein Deposition in Alzheimer's Disease

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preventive and Therapeutic Autoantibodies Protect against Neuronal Excitotoxicity;Journal of Psychiatry and Brain Science;2023

2. Biologically Active Fragment of the Receptor for Advanced Glycation End Products (RAGE) Is Able to Inhibit Oligomerization of the Beta-Amyloid;Russian Journal of Bioorganic Chemistry;2022-08

3. Intranasal Administration of a TRAIL Neutralizing Monoclonal Antibody Adsorbed in PLGA Nanoparticles and NLC Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer’s Disease;Biomedicines;2022-04-23

4. УЛЬТРАСТРУКТУРНИЙ СТАН СІТКІВКИ ТА ЗОРОВОГО НЕРВА В ЕКСПЕРИМЕНТІ НЕІНФЕКЦІЙНОГО ПЕРЕДНЬОГО ТА СЕРЕДНЬОГО УВЕЇТУ НА КРОЛЯХ БЕЗ ЛІКУВАННЯ ТА ПРИ ВИКОРИСТАННІ НЕЙРОПРОТЕКТОРА;Здобутки клінічної і експериментальної медицини;2020-09-29

5. Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau.P301S mouse model of Alzheimer’s disease and frontotemporal dementia;Alzheimer's Research & Therapy;2018-06-19